Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $543.43 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $360.98 | 3 | $0 (2024) |
| ARGENX US, INC. | $108.02 | 1 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $74.43 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71.76 | 1 | Galderma Laboratories, L.P. ($71.76) |
| 2023 | $326.87 | 3 | Galderma Laboratories, L.P. ($144.42) |
| 2022 | $144.80 | 1 | Galderma Laboratories, L.P. ($144.80) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $71.76 | General |
| 05/11/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $108.02 | General |
| Category: Immunology | ||||||
| 03/18/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $144.42 | General |
| 02/22/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO, DUOBRII | Food and Beverage | In-kind items and services | $74.43 | General |
| Category: Podiatry | ||||||
| 11/02/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $144.80 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 363 | 456 | $133,425 | $28,438 |
| 2022 | 13 | 490 | 631 | $147,889 | $34,449 |
| 2021 | 3 | 48 | 48 | $4,763 | $3,437 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 86 | $28,810 | $7,571 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 82 | $18,860 | $4,700 | 24.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $17,680 | $3,718 | 21.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 36 | 37 | $12,025 | $2,261 | 18.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 18 | $9,600 | $1,923 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,720 | $1,821 | 20.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 25 | $9,114 | $1,618 | 17.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 39 | 40 | $8,775 | $1,480 | 16.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $6,625 | $1,216 | 18.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $6,450 | $1,002 | 15.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $2,856 | $703.52 | 24.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 23 | 85 | $3,910 | $424.34 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 78 | $26,130 | $7,020 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 106 | $24,380 | $6,586 | 27.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $11,225 | $2,939 | 26.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 46 | 46 | $13,340 | $2,912 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $12,750 | $2,757 | 21.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 33 | 34 | $10,268 | $2,559 | 24.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 66 | 70 | $14,766 | $2,541 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $7,920 | $1,537 | 19.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 14 | $6,580 | $1,527 | 23.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 14 | 14 | $5,460 | $1,287 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 31 | $4,588 | $1,262 | 27.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 49 | 159 | $7,632 | $804.10 | 10.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 19 | $2,850 | $717.64 | 25.2% |
About Dr. Ryan Ladd, MD
Dr. Ryan Ladd, MD is a MOHS-Micrographic Surgery healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2020. The National Provider Identifier (NPI) number assigned to this provider is 1508494592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Ladd, MD has received a total of $543.43 in payments from pharmaceutical and medical device companies, with $71.76 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($543.43).
As a Medicare-enrolled provider, Ladd has provided services to 901 Medicare beneficiaries, totaling 1,135 services with total Medicare billing of $66,324. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Rochester, MN
- Active Since 03/27/2020
- Last Updated 12/23/2025
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1508494592
Products in Payments
- VYVGART (Drug) $108.02
- JUBLIA (Drug) $74.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Rochester
Marc Brown, Md, MD
MOHS-Micrographic Surgery — Payments: $11,011
Jonathan Soh, M.d, M.D
MOHS-Micrographic Surgery — Payments: $1,777
Gian Vinelli, M.d, M.D
MOHS-Micrographic Surgery — Payments: $1,123
Allison Robbins, Md, MD
MOHS-Micrographic Surgery — Payments: $364.32
Mr. Jose Cortez
MOHS-Micrographic Surgery — Payments: $284.02
Elliott Campbell, Md, MD
MOHS-Micrographic Surgery — Payments: $204.75